Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

IDEX Corporation to Webcast Third Quarter 2022 Earnings Call


IDEX CORPORATION (NYSE:IEX) announced today that it has scheduled the broadcast of the company's third quarter earnings conference call over the Internet on Wednesday, October 26, 2022 at 9:30 a.m. CT. Chief Executive Officer and President Eric Ashleman and Senior Vice President and Chief Financial Officer, William Grogan will discuss the company's third quarter 2022 financial performance and respond to questions from the financial community.

IDEX invites interested investors to listen to the call and view the presentation slides, which will be available on its website: www.idexcorp.com. To hear the live call, log on to the site several minutes before the discussion begins. After clicking on the presentation icon, follow the instructions to ensure your system is set up for the event, or download the correct applications at no charge. An archive of the webcast will be available through the IDEX website after the call. An audio replay of the call is also available through midnight, November 26, 2022 by dialing 877.660.6853 or (201.612.7415) for international participants using conference code # 13724805

About IDEX

IDEX (NYSE: IEX) is a company that has undoubtedly touched your life in some way. In fact, IDEX businesses make thousands of products that are mission-critical components in everyday activities. Chances are the car you're driving has a BAND-IT® clamp holding your side airbag safely in place. If you were ever in a car accident, a Hurst Jaws of Life® rescue tool may have saved your life. If you or a family member is battling cancer, your doctor may have tested your DNA in a quest to find the best targeted medicine for you. It's likely your DNA test was run on equipment that contains components made by our IDEX Health & Science team. Founded in 1988 with three small, entrepreneurial manufacturing companies, we're proud to say that we now call over 45 diverse businesses around the world part of the IDEX family. With more than 8,000 employees and manufacturing operations in more than 20 countries, IDEX is a high-performing, global company with nearly $2.8 billion in sales, committed to making trusted solutions that improve lives. IDEX shares are traded on the New York Stock Exchange under the symbol "IEX".

For further information on IDEX Corporation and its business units, visit the company's website at www.idexcorp.com.


These press releases may also interest you

26 nov 2022
A study in the journal BMJ Global Health found that mothers who were exposed to a lot of digital marketing were less likely to breastfeed their babies for the first six months of their lives and more likely to give them processed foods and sugary...

25 nov 2022
Vaccine candidate has the potential to be the first available to help protect adults aged 60 years and older from lower respiratory tract disease caused by respiratory syncytial virusApplication includes important pivotal phase III data evaluating...

25 nov 2022
Summary Brand: LebbyProduct: Dark Chocolate Chickpea SnacksCompanies: Ecoideas Innovations Inc.Issue: Food ? Allergen ? MilkCategory: Candy, confectionary, snacks and sweetenersWhat to do: Do not consume recalled products to which you are allergic or...

25 nov 2022
It's easy to find personal training in New Braunfels, Texas, but it's difficult to find someone that's committed and focused on your goals. Health Yourzelf is the leader in personal training in the Comal County region. Led by Matt Zampas, he...

25 nov 2022
XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, has received notification from the Nasdaq Stock Market LLC Listing...

25 nov 2022
IMV Inc. ("IMV" or the "Company") , a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and hematologic cancers, today announced that, on November 22, 2022, the Company...



News published on 26 september 2022 at 15:45 and distributed by: